Stay updated on NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Sign up to get notified when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.

Latest updates to the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page
- Check3 days agoChange DetectedAdded a dedicated Locations section listing site locations across Arkansas, California, Florida, Maryland, Missouri, New Jersey, Ohio, and Texas, and updated the page revision to v3.3.3. Removed the prior state-specific location subsections as part of the reorganization.SummaryDifference1%

- Check10 days agoChange DetectedAdded related topics links for Schizophrenia and MedlinePlus Genetics in the related topics section. These changes provide quick access to background information without altering the study data or its core content.SummaryDifference0.2%

- Check17 days agoChange DetectedRemoved the 'Schizophrenia' keyword and the 'MedlinePlus Genetics' related topics from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoChange DetectedOnly the revision label was updated from v3.3.1 to v3.3.2, with no changes to study details, inclusion/exclusion criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 on the page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page deleted a government funding and operating status notice that previously appeared on the study record. The removal does not affect core trial information such as eligibility criteria, interventions, outcomes, or listed locations; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.